Welcome to our dedicated page for Enact Holdings SEC filings (Ticker: ACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Enact Holdings, Inc. (Nasdaq: ACT) SEC filings, offering a detailed view of how the U.S. private mortgage insurance provider reports its financial condition, capital structure and material events. As a public company headquartered in Raleigh, North Carolina and operating through Enact Mortgage Insurance Corporation, Enact uses its filings to disclose information that is central to understanding its mortgage insurance business.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, investors can review Enact’s discussion of primary insurance in-force, new insurance written, loss experience, capital sufficiency relative to Private Mortgage Insurer Eligibility Requirements, and the impact of reinsurance and credit facilities. Current reports on Form 8-K supplement these periodic filings by describing specific events, such as the announcement of quarterly financial results or the entry into a senior unsecured revolving credit facility.
Enact’s filings also include details on its credit risk transfer activities, including quota share and excess of loss reinsurance agreements with panels of highly rated reinsurers. These documents explain how portions of expected new insurance written for future book years are covered and how such arrangements affect risk and capital management. The credit agreement filed as an exhibit to an 8-K outlines the terms of the revolving credit facility, including financial covenants tied to consolidated net worth, debt-to-total capitalization and PMIERs compliance.
On Stock Titan, SEC documents for ACT are updated in near real time as they are posted to the EDGAR system. AI-powered summaries help interpret complex sections of 10-Ks, 10-Qs and 8-Ks by highlighting key points about earnings, capital, reinsurance structures and covenants. Users can also review insider and executive transaction reports on Form 4, along with proxy and governance filings, with AI-generated explanations that clarify how these disclosures relate to Enact’s mortgage insurance operations and its relationship with majority owner Genworth Financial, Inc.
Robert Restrepo has filed a notice of proposed sale of 5,000 shares of the issuer’s common stock on NASDAQ through Fidelity Brokerage Services LLC. The filing lists an aggregate market value of $214,750.00 for these shares and an approximate sale date of February 11, 2026. As context, the number of common shares outstanding is shown as 144,395,767. Restrepo acquired the 5,000 shares in an open market purchase from the issuer on September 16, 2021, paid in cash.
The notice also discloses that during the past three months, Restrepo sold 2,562 and 7,438 common shares on November 18 and 19, 2025, for gross proceeds of $95,848.92 and $278,106.82, respectively. By signing, the seller represents that he is not aware of undisclosed material adverse information about the issuer’s operations.
Enact Holdings, Inc. filed a current report describing new capital actions and recent results communications. The company’s board approved a share repurchase program for up to $500 million of outstanding common stock and entered into a stock repurchase agreement with Genworth Financial, Inc.
Enact also furnished a press release and financial supplement covering its financial results for the quarter ended December 31, 2025. These materials, along with a press release on the repurchase program and dividend declaration, are provided as exhibits and are furnished rather than filed under securities laws.
Genworth Holdings, Inc., a major shareholder of Enact Holdings, Inc., reported selling 634,953 shares of Enact common stock on January 30, 2026. The sale was made to Enact under a previously signed Share Repurchase Agreement at a price of $39.3661 per share.
After this transaction, Genworth Holdings beneficially owns 114,588,830 Enact common shares, which represents approximately 81% of Enact’s outstanding common stock. The transaction reflects an internal share repurchase arrangement rather than an open-market sale to third-party investors.
Enact Holdings, Inc. reported that one of its directors acquired 165 deferred stock units on December 11, 2025 through reinvestment of a cash dividend paid at $0.21 per share.
These deferred stock units become payable in shares of common stock one year after the director’s service as a director ends. After this transaction, the director beneficially owns 30,543.457 deferred stock units, held directly and recorded at a price of $0 per unit.
Enact Holdings, Inc. reported that one of its directors acquired 165 deferred stock units on December 11, 2025 through dividend reinvestment at $0.21 per share. These deferred stock units will be paid out in shares of common stock one year after the director’s board service ends.
After this transaction, the director beneficially owns 30,543.457 deferred stock units, held directly.
Enact Holdings, Inc. reported that one of its officers, serving as Controller, acquired additional restricted stock units (RSUs) tied to existing equity awards. The RSUs were credited on December 11, 2025 under dividend reinvestment terms connected to a quarterly cash dividend of $0.21 per share.
Each restricted stock unit is structured to settle into one share of common stock on a 1:1 basis. The affected RSU awards vest and convert to common stock in three equal annual installments, with different grants beginning on February 9, 2024, February 16, 2025, April 1, 2025, February 21, 2026, and October 1, 2026. The transactions were reported as acquisitions at a $0 exercise price, reflecting their nature as stock-based compensation rather than open-market purchases.
Enact Holdings, Inc. reported that an officer serving as EVP and Chief Risk Officer acquired additional restricted stock units on December 11, 2025. The filing shows three small additions of 16, 27 and 33 restricted stock units, each settling into one share of common stock and credited at a price of $0 under existing awards.
Footnotes explain that these extra units were issued under dividend reinvestment terms following a quarterly cash dividend of $0.21 per share paid on December 11, 2025. The related restricted stock unit awards vest in three equal annual installments beginning on February 9, 2024, February 16, 2025 and February 21, 2026.
Enact Holdings, Inc. reported an insider equity change involving one of its directors. On December 11, 2025, the director acquired 31 deferred stock units through dividend reinvestment tied to a $0.21 per share dividend. These deferred stock units are payable in shares of common stock one year after the director’s service ends. Following this transaction, the director beneficially owns 5,688.256 deferred stock units.
Enact Holdings, Inc. reported an equity award update for its EVP & Chief Operations Officer. On December 11, 2025, the officer acquired 14, 22 and 26 restricted stock units at $0 per unit under dividend reinvestment terms tied to a quarterly dividend of $0.21 per share paid on that date.
Each restricted stock unit will settle into one share of Enact common stock. The underlying grants vest and convert to common stock in three equal annual installments beginning on February 9, 2024, February 16, 2025 and February 21, 2026, respectively. After these transactions, reported restricted stock unit holdings for the three grants were 2,609, 4,006 and 4,864 units, all held directly.
Enact Holdings, Inc. disclosed that one of its directors acquired 142 deferred stock units on December 11, 2025. These deferred stock units are linked to Enact’s common stock and will be paid out in shares one year after the director’s service on the board ends.
The 142 additional units were credited under a director award agreement through dividend reinvestment from a cash dividend paid on December 11, 2025 at $0.21 per share. After this transaction, the director beneficially owns 26,492.538 deferred stock units, held directly.